Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Oncology Institute (TOI) EBT Margin (2021 - 2025)

Oncology Institute (TOI) has disclosed EBT Margin for 5 consecutive years, with 12.09% as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, EBT Margin rose 404.0% year-over-year to 12.09%, compared with a TTM value of 14.4% through Sep 2025, up 421.0%, and an annual FY2024 reading of 16.44%, up 919.0% over the prior year.
  • EBT Margin was 12.09% for Q3 2025 at Oncology Institute, up from 14.31% in the prior quarter.
  • Across five years, EBT Margin topped out at 35.29% in Q1 2022 and bottomed at 39.31% in Q1 2023.
  • Average EBT Margin over 5 years is 11.95%, with a median of 15.7% recorded in 2024.
  • The sharpest move saw EBT Margin soared 3689bps in 2022, then plummeted -7460bps in 2023.
  • Year by year, EBT Margin stood at 24.14% in 2021, then skyrocketed by 34bps to 15.92% in 2022, then plummeted by -40bps to 22.23% in 2023, then skyrocketed by 41bps to 13.15% in 2024, then rose by 8bps to 12.09% in 2025.
  • Business Quant data shows EBT Margin for TOI at 12.09% in Q3 2025, 14.31% in Q2 2025, and 18.76% in Q1 2025.